APR 15, 2017 6:26 PM PDT

Aspirin Therapy Not As Effective As Previously Thought

WRITTEN BY: Kara Marker

How effective is aspirin for treating peripheral vascular disease, really? A large-scale meta-analysis introduces the idea that aspirin could be not very effective at all, potentially even harmful. The new study calls for more experiments to make a definitive statement on the efficacy of aspirin for treating peripheral vascular disease (PVD) and other heart conditions.

PVD consists of blood vessel maladies outside of those in the heart and brain - arteries that carry blood to the limbs, stomach, and kidneys. Two forms of PVD determine a range of possible symptoms; functional PVD involves no physical damage to the blood vessels and is characterized by fluctuating muscle spasms, and organic PVD describes structural changes to blood vessels, causing inflammation and tissue damage. Overall PVD is accompanied by a reduction in blood flow, affecting more than eight million people in the United States.

Aspirin is a classic example of a common drug used to treat heart and blood vessel conditions, like PVD. This drug prevents blood clots from forming, subsequently reducing the risk of adverse cardiac events. However, aspirin’s mechanism of action can backfire, sometimes increasing a person’s risk of hemorrhagic stroke or internal bleeding.

Cardiologist Anthony A Bavry, MD, says that many PVD patients “may not be deriving the benefits from aspirin that they expect to be getting.”

The University of Florida study included a meta-analysis of 11 aspirin therapy trials including more than six thousand PVD patients participating in studies. Statistics gleaned from the 11 trials  showed that aspirin had “no significant effect on death rates and incidents of stroke, heart attack, or major cardiac events.”

"Aspirin might not be a miracle drug for certain patients,” said co-author Ahmed N. Mahmoud, MD. “We need to reconsider the evidence, and see who benefits from aspirin therapy and who does not.”

The present study was published in the journal PLOS One.

Sources: University of Florida, American Heart Association

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
AUG 24, 2021
Health & Medicine
Myocarditis and COVID-19 Vaccination
AUG 24, 2021
Myocarditis and COVID-19 Vaccination
Myocarditis has been linked to sudden cardiac death in young, healthy athletes and smallpox, influenza, hepatitis B, and ...
SEP 02, 2021
Cancer
When Cholesterol Doesn't Kill Cancer, it Makes it Stronger!
SEP 02, 2021
When Cholesterol Doesn't Kill Cancer, it Makes it Stronger!
High cholesterol is associated with an increased risk of several types of cancer, and cancer patients with high choleste ...
AUG 26, 2021
Coronavirus
Researchers View COVID-19 Progression in a Live Animal Model
AUG 26, 2021
Researchers View COVID-19 Progression in a Live Animal Model
Scientists have used a mouse model to visualize the progression of a SARS-CoV-2 infection as it led to sometimes fatal c ...
AUG 29, 2021
Cell & Molecular Biology
Learning More About How a microRNA is Involved in ALS
AUG 29, 2021
Learning More About How a microRNA is Involved in ALS
The loss of a microRNA might be interfering with neuromuscular synapse function, causing breathing muscle paralysis, sug ...
SEP 16, 2021
Cancer
Inspiring Hope during Childhood Cancer Awareness Month
SEP 16, 2021
Inspiring Hope during Childhood Cancer Awareness Month
Childhood cancers, also known as pediatric cancers, are diagnosed in patients up to 14 years old.  Estimates for 20 ...
SEP 07, 2021
Health & Medicine
Vaccines- a Long History of Cost-Benefit Analysis
SEP 07, 2021
Vaccines- a Long History of Cost-Benefit Analysis
Vaccination and new treatments for diseases have remained topics of skepticism since their inception. When it came to an ...
Loading Comments...